Treatment Approach for Bronchopneumonia and Transaminitis in Infants

Initial Assessment and Management

Hospitalization is necessary for infants under 3 months with pneumonia due to higher risk of severe disease and complications, as recommended by the Infectious Diseases Society of America 1, 2
Intravenous antibiotics should be initiated promptly after obtaining appropriate cultures, with first-line antibiotic therapy being ampicillin or penicillin G for fully immunized infants, as suggested by the Infectious Diseases Society of America 1, 2
For infants not fully immunized or in areas with significant pneumococcal resistance, ceftriaxone or cefotaxime is recommended by the Infectious Diseases Society of America 2

If community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is suspected, add vancomycin or clindamycin to the treatment regimen, as recommended by the Infectious Diseases Society of America 1, 2
For suspected atypical pneumonia, consider adding azithromycin to the β-lactam antibiotic, as suggested by the Infectious Diseases Society of America 2

Provide supplemental oxygen to maintain oxygen saturation >90%, as recommended by the Infectious Diseases Society of America 3
Monitor respiratory status closely, including work of breathing, respiratory rate, and oxygen saturation, as suggested by the Infectious Diseases Society of America 3

Evaluate for potential causes of transaminitis, including viral infections, medication effects, or systemic illness, as recommended by the Infectious Diseases Society of America 3
Monitor liver function tests regularly during treatment, as suggested by the Infectious Diseases Society of America 4
Adjust medication dosing as needed based on liver function, as recommended by the Infectious Diseases Society of America 2

Assess for clinical improvement within 48-72 hours of initiating therapy, as recommended by the Infectious Diseases Society of America 1
If no improvement or clinical deterioration occurs within this timeframe, further investigation is warranted, as suggested by the Infectious Diseases Society of America 1
Consider additional diagnostic testing, including imaging to assess progression of pneumonia or development of complications, as recommended by the Infectious Diseases Society of America 5

For parapneumonic effusions, chest radiography should be used for confirmation, with ultrasound or CT if radiographs are inconclusive, as recommended by the Infectious Diseases Society of America 2
Small effusions may be managed with antibiotics alone, while moderate to large effusions may require drainage, as suggested by the Infectious Diseases Society of America 6, 4
Pulmonary abscesses can initially be treated with intravenous antibiotics; surgical drainage is rarely needed, as recommended by the Infectious Diseases Society of America 5

For uncomplicated pneumonia, antibiotic treatment typically continues for 7-10 days, as recommended by the Infectious Diseases Society of America 1
For complicated cases with effusions or abscesses, treatment for 2-4 weeks is generally adequate, as suggested by the Infectious Diseases Society of America 6
Continue intravenous antibiotics until significant clinical improvement, then consider transition to oral therapy if appropriate, as recommended by the Infectious Diseases Society of America 3

Overall clinical improvement, including activity, appetite, and decreased fever for at least 12-24 hours, is necessary for discharge, as recommended by the Infectious Diseases Society of America 3
Consistent pulse oximetry measurements >90% in room air for at least 12-24 hours, stable or baseline mental status, and no substantially increased work of breathing or sustained tachypnea or tachycardia are also required for discharge, as suggested by the Infectious Diseases Society of America 3